GENE ONLINE|News &
Opinion
Blog

FDA Approval
Trials & Approvals Rare Disease
BridgeBio Bags First FDA Nod with Rare Disease Drug Acquired from Alexion
2021-03-03
Trials & Approvals Lymphoma
TG Therapeutics Gets Conditional FDA Okay for its First Lymphoma Drug
2021-02-09
Trials & Approvals HIV
Game-Changing Antiretroviral Regimen from ViiV Receives FDA Approval
2021-01-22
Trials & Approvals Cystic Fibrosis
FDA Approves 3 Cystic Fibrosis Drugs of Vertex for Patients with Rare Mutations
2020-12-24
Trials & Approvals Rare Disease
Orladeyo’s FDA approval Heralds New Funding for BioCryst
2020-12-13
Trials & Approvals Liver Enzyme
Alnylam Receives FDA Nod for its Third Rare Disease Drug
2020-11-25
Trials & Approvals NGS
Foundation Medicine’s Liquid Biopsy Test Bags FDA Approval for Eighth Indication as Companion Diagnostic
2020-11-10
COVID-19
First to the Finish Line! Remdesivir Becomes the First and Only FDA Approved Drug to Treat COVID-19
2020-10-23
Trials & Approvals
FDA Approves Venetoclax Combination for New Acute Myeloid Leukemia Cases
2020-10-19
COVID-19 EVD
Regeneron’s FDA Success with Ebola Treating Antibody Cocktail, Inmazeb, Bodes Well for its COVID-19 Candidate
2020-10-16
Trials & Approvals
FDA Approves Treatment for Aggressive Form of Mesothelioma After Sixteen Long Years
2020-10-04
Trials & Approvals
FDA Greenlights Eton and Diurnal’s Orphan Drug for Pediatric Patients
2020-10-04
Trials & Approvals Darolutamide
Darolutamide Improves Survival in Nonmetastatic Castration Resistant Prostate Cancer Patients
2020-09-18
R&D Cancer
3SBio Partnering with Samsung Bioepis Co-developing Bevacizumab Biosimilar for NSCLC
2020-09-16
Trials & Approvals Epigenetic Modifier
Bristol Myers Squibb Notches Key Regulatory Win for Oral Formulation of Epigenetic Modifier
2020-09-06
1 … 5 6 7 8 9
LATEST
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top